AU - 
TI - New Trials Comparing Protease Inhibitors and Nonnucleoside Analogs will Assess Reductions in Cardiovascular Risk Besides Antiviral Efficacy in First-line Therapies
PT - Journal Article
DP - 2024
TA - Anales Médicos
AID - No especificado